Suchergebnisse - Patel, P M
- Treffer 1 - 12 von 12
-
1
Increasing the brain's tolerance to ischemia in the operating room. von Patel, P M, U, H S
Veröffentlicht 1997Text -
2
Do surgeons wish to become doctors? von Ibery, N, Patel, P M, Robb, P J
Veröffentlicht 2006Text -
3
Interleukin 12: a new clinical player in cytokine therapy. von Banks, R. E., Patel, P. M., Selby, P. J.
Veröffentlicht 1995Text -
4
Anthraquinone laxatives and human cancer: an association in one case. von Patel, P. M., Selby, P. J., Deacon, J., Chilvers, C., McElwain, T. J.
Veröffentlicht 1989Text -
5
-
6
A phase II study of a 5T4 oncofoetal antigen tumour-targeted superantigen (ABR-214936) therapy in patients with advanced renal cell carcinoma von Shaw, D M, Connolly, N B, Patel, P M, Kilany, S, Hedlund, G, Nordle, Ö, Forsberg, G, Zweit, J, Stern, P L, Hawkins, R E
Veröffentlicht 2007Text -
7
-
8
-
9
Inhibition of p75 neurotrophin receptor does not rescue cognitive impairment in adulthood after isoflurane exposure in neonatal mice von Schilling, J.M., Kassan, A., Mandyam, C., Pearn, M.L., Voong, A., Grogman, G.G., Risbrough, V.B., Niesman, I.R., Patel, H.H., Patel, P.M., Head, B.P.
Veröffentlicht 2017Text -
10
Inhibition of RhoA reduces propofol-mediated growth cone collapse, axonal transport impairment, loss of synaptic connectivity, and behavioural deficits von Pearn, M.L., Schilling, J.M., Jian, M., Egawa, J., Wu, C., Mandyam, C.D., Fannon-Pavlich, M.J., Nguyen, U., Bertoglio, J., Kodama, M., Mahata, S.K., DerMardirossian, C., Lemkuil, B.P., Han, R., Mobley, W.C., Patel, H.H., Patel, P.M., Head, B.P.
Veröffentlicht 2018Text -
11
Adjuvant bevacizumab for melanoma patients at high risk of recurrence: survival analysis of the AVAST-M trial von Corrie, P G, Marshall, A, Nathan, P D, Lorigan, P, Gore, M, Tahir, S, Faust, G, Kelly, C G, Marples, M, Danson, S J, Marshall, E, Houston, S J, Board, R E, Waterston, A M, Nobes, J P, Harries, M, Kumar, S, Goodman, A, Dalgleish, A, Martin-Clavijo, A, Westwell, S, Casasola, R, Chao, D, Maraveyas, A, Patel, P M, Ottensmeier, C H, Farrugia, D, Humphreys, A, Eccles, B, Young, G, Barker, E O, Harman, C, Weiss, M, Myers, K A, Chhabra, A, Rodwell, S H, Dunn, J A, Middleton, M R
Veröffentlicht 2018Text -
12
Adjuvant bevacizumab for melanoma patients at high risk of recurrence: survival analysis of the AVAST-M trial von Corrie, P G, Marshall, A, Nathan, P D, Lorigan, P, Gore, M, Tahir, S, Faust, G, Kelly, C G, Marples, M, Danson, S J, Marshall, E, Houston, S J, Board, R E, Waterston, A M, Nobes, J P, Harries, M, Kumar, S, Goodman, A, Dalgleish, A, Martin-Clavijo, A, Westwell, S, Casasola, R, Chao, D, Maraveyas, A, Patel, P M, Ottensmeier, C H, Farrugia, D, Humphreys, A, Eccles, B, Young, G, Barker, E O, Harman, C, Weiss, M, Myers, K A, Chhabra, A, Rodwell, S H, Dunn, J A, Middleton, M R
Veröffentlicht 2019Text